Masashi Kanai Selected Research

Masashi Kanai Research Topics

Disease

51	Neoplasms (Cancer) 04/2024 - 01/2004
21	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2024 - 06/2011
20	Pancreatic Neoplasms (Pancreatic Cancer) 09/2023 - 04/2008
8	Stroke (Strokes) 10/2023 - 10/2016
6	Stomach Neoplasms (Stomach Cancer) 01/2016 - 12/2002
4	Disease Progression 03/2024 - 01/2010
4	Neoplasm Metastasis (Metastasis) 02/2019 - 04/2014
4	Colorectal Neoplasms (Colorectal Cancer) 07/2018 - 01/2008
3	Lymphatic Metastasis 04/2024 - 04/2005
3	Heart Failure 01/2023 - 03/2020
3	Sarcopenia 10/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2010
2	COVID-19 01/2022 - 08/2021
2	Myocardial Infarction 12/2021 - 06/2021
2	Adenocarcinoma 10/2020 - 04/2018
2	Colonic Neoplasms (Colon Cancer) 05/2020 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2018 - 04/2017
2	Esophageal Neoplasms (Esophageal Cancer) 09/2017 - 06/2007
1	Neuroendocrine Carcinoma 04/2024
1	Thyroid Neoplasms (Thyroid Cancer) 03/2024
1	Glioma (Gliomas) 03/2024
1	Heart Diseases (Heart Disease) 11/2023
1	Turcot syndrome 10/2023
1	Microsatellite Instability 10/2023
1	Malnutrition (Nutritional Deficiencies) 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Teratoma (Teratoid Tumor) 12/2022
1	Cholangiocarcinoma 11/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2022
1	Bile Duct Neoplasms (Bile Duct Cancer) 10/2022
1	Acinar Cell Carcinoma 10/2022
1	Body Weight (Weight, Body) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 12/2021
1	Atrial Fibrillation 12/2021
1	Frailty 05/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2020
1	Diabetes Mellitus 03/2020

Drug/Important Bio-Agent (IBA)

19	Gemcitabine FDA Link 12/2023 - 04/2008
9	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 05/2012
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023 - 01/2008
6	CurcuminIBA 11/2022 - 07/2011
5	Proteins (Proteins, Gene)FDA Link 03/2020 - 12/2002
4	Leucovorin (Folinic Acid)FDA Link 01/2019 - 01/2008
4	S 1 (combination)IBA 12/2016 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2019
3	Oxygen (Dioxygen)IBA 11/2023 - 06/2021
3	NivolumabIBA 10/2023 - 12/2015
3	PlatinumIBA 10/2022 - 12/2015
3	Formaldehyde (Formol)FDA Link 01/2022 - 05/2019
3	ParaffinIBA 01/2022 - 05/2019
3	Carcinoembryonic AntigenIBA 12/2020 - 04/2014
3	C-Reactive ProteinIBA 10/2016 - 04/2014
3	CarbohydratesIBA 11/2015 - 04/2014
3	AntigensIBA 11/2015 - 04/2014
3	Fluorouracil (Carac)FDA LinkGeneric 05/2012 - 01/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2024 - 04/2009
2	Clostridium perfringens epsilon-toxinIBA 11/2023 - 12/2021
2	Immune Checkpoint InhibitorsIBA 10/2023 - 12/2019
2	folfirinoxIBA 01/2023 - 11/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2022
2	Circulating Tumor DNAIBA 11/2022 - 10/2022
2	AfatinibIBA 01/2022 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2020 - 01/2016
2	CreatinineIBA 03/2020 - 10/2019
2	Messenger RNA (mRNA)IBA 12/2010 - 12/2002
2	Docetaxel (Taxotere)FDA Link 10/2010 - 06/2007
1	Etoposide (VP 16)FDA LinkGeneric 04/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	capmatinibIBA 04/2024
1	dabrafenibIBA 03/2024
1	trametinibIBA 03/2024
1	Poly Adenosine Diphosphate RiboseIBA 04/2023
1	beta-Aminoethyl Isothiourea (AET)IBA 02/2023
1	Sorafenib (BAY 43-9006)FDA Link 12/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2020
1	GlucuronidesIBA 05/2020
1	ProdrugsIBA 05/2020
1	NF-kappa B (NF-kB)IBA 05/2020
1	A-factor (Streptomyces)IBA 04/2020

Therapy/Procedure

35	Drug Therapy (Chemotherapy) 04/2024 - 01/2004
21	Therapeutics 04/2024 - 01/2004
9	Genomic Medicine 04/2024 - 04/2019
5	Neoadjuvant Therapy 12/2023 - 11/2017
5	Activities of Daily Living (ADL) 10/2023 - 07/2018
5	Precision Medicine 08/2022 - 05/2016
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2023 - 05/2018
4	Cardiac Rehabilitation 01/2023 - 03/2020
4	Radiotherapy 11/2022 - 11/2017
3	Length of Stay 02/2022 - 03/2020
3	Hepatectomy 01/2015 - 06/2014
2	Adjuvant Chemotherapy 02/2019 - 06/2014
2	Chemoradiotherapy 09/2017 - 11/2015
1	Braces 01/2022